AMANDA HATCHER: Open Payments
NPI 1679183115 · BASSETT, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 22 payments from 11 companies in 2025. Trend: 2023 $213 · 2024 $307 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| ABBVIE INC. | 3 | $46 |
| Medtronic, Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $25 |
| Abbott Laboratories | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: Korlym, CAPLYTA, SYNCHROMEDII, VRAYLAR, FREESTYLE LIBRE 3, VIVITROL, XIFAXAN, Kerendia.
Industry payments across VA — which companies pay providers there.
